Skip to main content
Caplight Logo









Marine Biomedical

Marine Biomedical

Private
BroomeHealthcare & Life Scienceshttps://www.marinebiomedical.com.au/

Last Round

Strategic

Jan 16, 2026

Total Funding Raised

$3.15M

Momentum

Top 50%

of companies Caplight tracks

Company Overview

Marine Biomedical is a biotechnology company that develops and manufactures marine-derived biomaterials, including its flagship bone substitute product PearlBone™, for use in orthopaedic and dental applications.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Biotechnology, Advanced Materials, Sustainable Materials, Circular Economy

Business Model

B2B

Customer Profile

Services & Consulting

AI Layer

Non-AI

Keywords

bone graft substitutebiomaterialsregenerative medicinebone graftnacrebiocompatible scaffoldsorthopaedic surgerydental surgerymedical device manufacturerbone regenerationbiotechmother of pearlmedtechFDA 510(k)circular economy

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Marine Biomedical Comparables

Compare Marine Biomedical with similar companies based on industry and business-model similarity.

Marine Biomedical comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
CoreBone
83%
Zoan BioMed
82%
Molecular Matrix, Inc.
78%

Marine Biomedical Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
StrategicJan 16, 2026
Early FundingMay 1, 2025
GrantMay 17, 2022

Key People

Founding team and executive leadership

Rolee Kumar

Chief Executive Officer

Executive Team

Marine Biomedical Investors

Notable investors and investment history

Marine Biomedical investors
InvestorRounds
Government of Western AustraliaGrant

Market signals

Structured signals derived from secondary market and firmographic data.

  • Apr 1, 2026

    Monthly visitors grew 251% MoM, reaching 842.

  • Jan 16, 2026

    $740K raised, led by Orthocell Ltd

Marine Biomedical Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Marine Biomedical Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Marine Biomedical's valuation, stock price, and market status.

Firmographic Details

HeadquartersBroome
Employee Range9
Year Founded2021
Last FundingJan 16, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?